A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: Time to dispense with the hemoglobin A1C in end-stage kidney disease
Chronic kidney disease remains as one of the major complications for individuals with diabetes and contributes to considerable morbidity. Individuals subjected to dialysis therapy, half of whom are diabetic, experience a mortality of ∼20% per year. Understanding factors related to mortality remains...
Main Author: | Freedman, Barry I. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379614/ |
Similar Items
-
Molten Globule of Hemoglobin Proceeds into Aggregates and Advanced Glycated End Products
by: Iram, Afshin, et al.
Published: (2013) -
No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes
by: Selvin, Elizabeth, et al.
Published: (2013) -
Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease
by: Kuo, I-Ching, et al.
Published: (2016) -
Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil
by: Leite, Eliziane Brandão, et al.
Published: (2015) -
A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
by: Kalantar-Zadeh, Kamyar
Published: (2012)